Cardiovascular diseases such as arrhythmias, myocardial infarction and heart failure are the most common cause of death in the industrialised Western world and the cost for the society and the health care system to treat cardiovascular diseases is tremendous. It is of main importance to strengthen research activities to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of cardiovascular diseases.
Areas of research
The Cardiovascular Research Centre (CVRC) research environment is a network of approximately 40 members at Örebro University and Örebro University Hospital/Region Örebro County working with basic, translational and clinical research to identify new mechanisms, risk factors and new target principles for more effective diagnosis, treatment and prevention of cardiovascular diseases. The CVRC was founded in 2014 and the overall strategy is to support internal and external academic and industrial research collaboration and to contribute to a successful and high-quality third cycle education in the field of cardiovascular research. The CVRC has been ranked as a strong research environment by external evaluators.
News & Media
International Science Day- 10th November 2022
CVRC researcher Dr. Ashok Kumar Kumawat took part in the scientific activities on International Science Day, organized by Department of Science, SSG Pareek PG College, Jaipur, Rajasthan, India. Dr. Kumawat was invited as a keynote speaker and presented a...
Master's programme open for research: “We're thrilled to be at Örebro University”
For Jishamol Veettil and Myrto Chatzopoulou, the Master's Programme in Experimental Medicine was the starting point for a career in research at Örebro University. Now they work in the laboratory alongside teachers from their study programme. “Everyone...
Student Jan from Germany contributing to research on cardiovascular disease: “Have gained new perspectives”
Since early November, biomedical student Jan Bobrowski from Germany have worked alongside researchers at Örebro University’s Cardiovascular Research Centre to identify new drugs to treat cardiovascular disease.